ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET ANONIM SIRKETI

Income Statement Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi

Equities

ONCSM

TREONCO00026

Advanced Medical Equipment & Technology

Market Closed - Borsa Istanbul Other stock markets 16:09:56 04/10/2024 BST			5-day change	1st Jan Change
122.90 ^TRY	-9.96%		-10.29%	-17.85%

09-27	Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
06-20	Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

c7b4323278de8357.j2A_5VMIbjtQGzvwPJigAHOCB0ujLW_WY94qNR6sWeU.vi9bj2RYHXhkTWKAc-vaNwG0XSfAfBquL6caVFb9a7-_FmDRY0wDamJ_SA

Published financial data: ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET ANONIM SIRKETI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023
Revenues	128M	141M	241M
Total Revenues	128M	141M	241M
Cost of Goods Sold, Total	39.65M	79.23M	205M
Gross Profit	88.34M	61.3M	35.79M
Selling General & Admin Expenses, Total	15.73M	28.34M	80.85M
Other Operating Expenses	2.25M	1.01M	14.58M
Other Operating Expenses, Total	17.97M	29.34M	95.43M
Operating Income	70.37M	31.96M	-59.64M
Interest Expense, Total	-2.61M	-1.12M	-9.87M
Interest And Investment Income	11.19M	-	17.83M
Net Interest Expenses	8.58M	-1.12M	7.96M
Currency Exchange Gains (Loss)	2.55M	3.11M	-5.96M
Other Non Operating Income (Expenses)	-184K	-487K	-37.7M
EBT, Excl. Unusual Items	81.32M	33.46M	-95.35M
Gain (Loss) On Sale Of Investments	-	-	-247K
Legal Settlements	-903K	-1.71M	1.28M
EBT, Incl. Unusual Items	80.41M	31.75M	-94.32M
Income Tax Expense	8.68M	6.26M	-14.5M
Earnings From Continuing Operations	71.73M	25.49M	-79.81M
Net Income to Company	71.73M	25.49M	-79.81M
Net Income - (IS)	71.73M	25.49M	-79.81M
Net Income to Common Incl Extra Items	71.73M	25.49M	-79.81M
Net Income to Common Excl. Extra Items	71.73M	25.49M	-79.81M
Per Share Items
Net EPS - Basic	303.08	-	-3.37
Basic EPS - Continuing Operations	303.08	-	-3.37
Basic Weighted Average Shares Outstanding	237K	-	23.69M
Net EPS - Diluted	303.08	-	-3.37
Diluted EPS - Continuing Operations	303.08	-	-3.37
Diluted Weighted Average Shares Outstanding	237K	-	23.69M
Normalized Basic EPS	214.73	-	-2.52
Normalized Diluted EPS	214.73	-	-2.52
Dividend Per Share	-	0.41	-
Payout Ratio	-	-	-17.28
Supplemental Items
EBITDA	77.08M	41.87M	-26.63M
EBITA	70.37M	31.96M	-59.64M
EBIT	70.37M	31.96M	-59.64M
EBITDAR	77.45M	42.22M	-
Effective Tax Rate - (Ratio)	10.8	19.71	15.38
Total Current Taxes	8.8M	8.61M	-
Total Deferred Taxes	-120K	-2.36M	-14.5M
Normalized Net Income	50.82M	20.91M	-59.59M
Interest on Long-Term Debt	299K	344K	291K
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.79M	7.22M	14.22M
General and Administrative Expenses	13.57M	20.76M	66.26M
Net Rental Expense, Total	372K	348K	-
Imputed Operating Lease Interest Expense	-	219K	-
Imputed Operating Lease Depreciation	-	129K	-

Fiscal Period: December	2021	2022	2023
Assets
Cash And Equivalents	5.77M	11.68M	58.54M
Total Cash And Short Term Investments	5.77M	11.68M	58.54M
Accounts Receivable, Total	33.96M	41.18M	54.41M
Other Receivables	116K	51.44K	172K
Total Receivables	34.08M	41.23M	54.58M
Inventory	39.47M	53.64M	80.01M
Prepaid Expenses	191K	6.43M	1.26M
Other Current Assets, Total	5.85M	3.93M	813K
Total Current Assets	85.37M	117M	195M
Gross Property Plant And Equipment	58.52M	71.75M	276M
Accumulated Depreciation	-19.21M	-28.99M	-158M
Net Property Plant And Equipment	39.31M	42.76M	118M
Long-term Investments	-	386K	1.85M
Other Intangibles, Total	1.88M	1.05M	4.85M
Deferred Tax Assets Long-Term	2.42M	4.25M	8.03M
Deferred Charges Long-Term	0	0	0
Other Long-Term Assets, Total	581K	2.02M	10.22M
Total Assets	130M	167M	338M
Liabilities
Accounts Payable, Total	11.31M	15.78M	16.88M
Accrued Expenses, Total	3.51M	3.61M	6.29M
Short-term Borrowings	468K	7.63M	58.31M
Current Portion of Long-Term Debt	7.63M	3.05M	1.43M
Current Portion of Leases	1.63M	1.21M	1.28M
Current Income Taxes Payable	1.79M	217K	924K
Unearned Revenue Current, Total	6.2M	4.99M	2.79M
Deferred Tax Liability Current	8.8M	8.61M	-
Other Current Liabilities	2.73M	13.32M	2.67M
Total Current Liabilities	44.07M	58.42M	90.58M
Long-Term Debt	2.58M	1.26M	1.01M
Long-Term Leases	2.02M	933K	331K
Pension & Other Post Retirement Benefits	540K	1.73M	3.61M
Deferred Tax Liability Non Current	1.55M	1.08M	11.08M
Total Liabilities	50.75M	63.42M	107M
Common Stock, Total	19.9M	19.9M	23.85M
Additional Paid In Capital	-	-	95.91M
Retained Earnings	78.51M	104M	61.34M
Comprehensive Income and Other	-19.61M	-19.94M	50.6M
Total Common Equity	78.8M	104M	232M
Total Equity	78.8M	104M	232M
Total Liabilities And Equity	130M	167M	338M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	401K	-	23.85M
ECS Total Common Shares Outstanding	401K	-	23.85M
Book Value / Share	196.5	-	9.72
Tangible Book Value	76.92M	103M	227M
Tangible Book Value Per Share	191.83	-	9.51
Total Debt	14.32M	14.08M	62.37M
Net Debt	8.55M	2.4M	3.82M
Debt Equivalent Oper. Leases	2.97M	2.78M	-
Account Code - Inventory Valuation	-	6	6
Inventories - Raw Materials, Total	25.52M	34.21M	56.11M
Inventories - Finished Goods, Total	7.24M	15.17M	20.01M
Inventories - Others	347K	239K	1.52M
Buildings, Total	153K	153K	1.37M
Machinery, Total	45M	58.52M	230M
Full Time Employees	-	309	324
Accumulated Allowance for Doubtful Accounts (Supple)	1.71M	3.1M	15.26M

Fiscal Period: December	2021	2022	2023
Net Income	71.73M	25.49M	-79.81M
Depreciation & Amortization - CF	8M	11.11M	36.67M
Depreciation & Amortization, Total	8M	11.11M	36.67M
Amortization of Deferred Charges, Total - (CF)	-	-	2.38M
(Gain) Loss From Sale Of Asset	-	-	-247K
Provision and Write-off of Bad Debts	563K	1.39M	10.94M
Other Operating Activities, Total	8.73M	-5.23M	8.57M
Change In Accounts Receivable	-13.09M	-8.97M	429K
Change In Inventories	-27.96M	-16.51M	10.48M
Change In Accounts Payable	4.65M	4.81M	-8.91M
Change in Other Net Operating Assets	-894K	8.96M	-18.61M
Cash from Operations	51.73M	21.04M	-38.1M
Capital Expenditure	-10.96M	-13.95M	-27.72M
Sale of Property, Plant, and Equipment	-	-	10.68M
Cash Acquisitions	-24.35M	-	-
Sale (Purchase) of Intangible assets	-1.68M	-	-3.84M
Investment in Marketable and Equity Securities, Total	-	-386K	-802K
Other Investing Activities, Total	-796K	219K	-
Cash from Investing	-37.79M	-14.12M	-21.69M
Short Term Debt Issued, Total	-	2.2M	-
Long-Term Debt Issued, Total	353K	-	41.09M
Total Debt Issued	353K	2.2M	41.09M
Short Term Debt Repaid, Total	-5.95M	-	-
Long-Term Debt Repaid, Total	-8.68M	-2.44M	-1.42M
Total Debt Repaid	-14.64M	-2.44M	-1.42M
Issuance of Common Stock	-	-	102M
Common Dividends Paid	-	-	-13.79M
Common & Preferred Stock Dividends Paid	-	-	-13.79M
Other Financing Activities, Total	-2.31M	-773K	-9.58M
Cash from Financing	-16.59M	-1.01M	118M
Miscellaneous Cash Flow Adjustments	-	-	-19.23M
Net Change in Cash	-2.65M	5.91M	39.29M
Supplemental Items
Cash Interest Paid	2.31M	773K	9.58M
Cash Income Tax Paid (Refund)	-4.65M	6.42M	3.45M
Levered Free Cash Flow	-	2.99M	-39.97M
Unlevered Free Cash Flow	-	3.69M	-33.81M
Change In Net Working Capital	-	13.45M	4.01M
Net Debt Issued / Repaid	-14.29M	-238K	39.67M

Fiscal Period: December	2021	2022	2023
Profitability
Return on Assets	-	13.45	-10.84
Return on Total Capital	-	18.92	-13.77
Return On Equity %	-	27.9	-35.02
Return on Common Equity	-	27.9	-35.02
Margin Analysis
Gross Profit Margin %	69.02	43.62	14.88
SG&A Margin	12.29	20.16	33.62
EBITDA Margin %	60.23	29.8	-11.07
EBITA Margin %	54.98	22.74	-24.8
EBIT Margin %	54.98	22.74	-24.8
Income From Continuing Operations Margin %	56.05	18.14	-33.18
Net Income Margin %	56.05	18.14	-33.18
Net Avail. For Common Margin %	56.05	18.14	-33.18
Normalized Net Income Margin	39.71	14.88	-24.78
Levered Free Cash Flow Margin	-	2.13	-16.62
Unlevered Free Cash Flow Margin	-	2.62	-14.06
Asset Turnover
Asset Turnover	-	0.95	0.7
Fixed Assets Turnover	-	3.42	1.89
Receivables Turnover (Average Receivables)	-	3.74	3.93
Inventory Turnover (Average Inventory)	-	1.7	2.34
Short Term Liquidity
Current Ratio	1.94	2	2.16
Quick Ratio	0.9	0.91	1.25
Operating Cash Flow to Current Liabilities	1.17	0.36	-0.42
Days Sales Outstanding (Average Receivables)	-	97.58	92.78
Days Outstanding Inventory (Average Inventory)	-	214.46	155.79
Average Days Payable Outstanding	-	52.95	41.2
Cash Conversion Cycle (Average Days)	-	259.09	207.37
Long Term Solvency
Total Debt/Equity	18.17	13.54	26.92
Total Debt / Total Capital	15.38	11.93	21.21
LT Debt/Equity	5.83	2.11	0.58
Long-Term Debt / Total Capital	4.94	1.86	0.46
Total Liabilities / Total Assets	39.18	37.89	31.51
EBIT / Interest Expense	27	28.6	-6.04
EBITDA / Interest Expense	30.07	38.54	-2.33
(EBITDA - Capex) / Interest Expense	25.87	26.06	-5.14
Total Debt / EBITDA	0.18	0.33	-2.72
Net Debt / EBITDA	0.11	0.06	-0.17
Total Debt / (EBITDA - Capex)	0.21	0.48	-1.23
Net Debt / (EBITDA - Capex)	0.13	0.08	-0.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	9.8	-17.9
Gross Profit, 1 Yr. Growth %	-	-30.61	-64.46
EBITDA, 1 Yr. Growth %	-	-45.68	-140.58
EBITA, 1 Yr. Growth %	-	-54.59	-280.65
EBIT, 1 Yr. Growth %	-	-54.59	-280.65
Earnings From Cont. Operations, 1 Yr. Growth %	-	-64.46	284.37
Net Income, 1 Yr. Growth %	-	-64.46	284.37
Normalized Net Income, 1 Yr. Growth %	-	-58.85	-29.45K
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	96.85
Accounts Receivable, 1 Yr. Growth %	-	21.27	-19.81
Inventory, 1 Yr. Growth %	-	35.88	-15.55
Net Property, Plant and Equip., 1 Yr. Growth %	-	8.77	-13.72
Total Assets, 1 Yr. Growth %	-	29.2	-3.22
Tangible Book Value, 1 Yr. Growth %	-	33.78	2.79
Common Equity, 1 Yr. Growth %	-	31.93	3.4
Cash From Operations, 1 Yr. Growth %	-	-59.32	-172.32
Capital Expenditures, 1 Yr. Growth %	-	27.23	6.54
Levered Free Cash Flow, 1 Yr. Growth %	-	-	58.62
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	41.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	37.08
Gross Profit, 2 Yr. CAGR %	-	-	-36.35
EBITDA, 2 Yr. CAGR %	-	-	-41.23
EBITA, 2 Yr. CAGR %	-	-	-7.94
EBIT, 2 Yr. CAGR %	-	-	-7.94
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	5.48
Net Income, 2 Yr. CAGR %	-	-	5.48
Normalized Net Income, 2 Yr. CAGR %	-	-	8.28
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-89.46
Accounts Receivable, 2 Yr. CAGR %	-	-	26.58
Inventory, 2 Yr. CAGR %	-	-	42.37
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	73.36
Total Assets, 2 Yr. CAGR %	-	-	61.6
Tangible Book Value, 2 Yr. CAGR %	-	-	71.73
Common Equity, 2 Yr. CAGR %	-	-	71.48
Cash From Operations, 2 Yr. CAGR %	-	-	-14.17
Capital Expenditures, 2 Yr. CAGR %	-	-	59.01